Due to the tense situation of Novel Coronavirus Disease (COVID-19), company decided to pause the recruitment of Global Phase III clinical study for 3 months and will restart recruitment when epidemic gets controlled.

Date of occurrence of the event: Apr 06, 2020 Company name: OBI Pharma Inc. Relationship to the Company (please enter “head office” or “subsidiaries”): Head Office Reciprocal shareholding ratios: No applicable Cause of occurrence: Due to the tense situation of Novel Coronavirus Disease (COVID-19), OBI has participated in Global Biotechnology emergency responses. After consulting with […]